Condom HPV Warning Would Be Required Under Cervical Cancer Bill
This article was originally published in The Tan Sheet
Executive Summary
Condom labeling would be required to bear a warning that the devices do not provide adequate protection against the transmission of human papillomavirus (HPV) under an amendment to breast and cervical cancer treatment legislation pending in the House.
You may also be interested in...
Condom HIV Protection Supported By Panel, Other STDs Inconclusive
Latex condom use lowers the risk of acquiring HIV and gonorrhea, but study data on condoms' effectiveness at reducing the risk of other sexually transmitted diseases is inconclusive, according to a recent National Institutes of Health report.
Condom HIV Protection Supported By Panel, Other STDs Inconclusive
Latex condom use lowers the risk of acquiring HIV and gonorrhea, but study data on condoms' effectiveness at reducing the risk of other sexually transmitted diseases is inconclusive, according to a recent National Institutes of Health report.
Condom HIV Protection Supported By Panel, Other STDs Inconclusive
Latex condom use lowers the risk of acquiring HIV and gonorrhea, but study data on condoms' effectiveness at reducing the risk of other sexually transmitted diseases is inconclusive, according to a recent National Institutes of Health report.